Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Hersentraining helpt mogelijk parkinsonpatiënt
jan 2017 | Bewegingsstoornissen
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen